FDA Inspection 584937 — Oxygen Development, L.L.C.

Oxygen Development, L.L.C. — FEI 3009461317

The FDA completed an inspection of Oxygen Development, L.L.C. on May 29, 2009 in Palm Springs, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 29, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Palm Springs, FL (United States)

Citations

IDCFRDescription
188321 CFR 211.165(a)Testing and release for distribution
194321 CFR 211.180(e)(1)Review of representative number of batches
200921 CFR 211.188Prepared for each batch, include complete information
202621 CFR 211.192Quality control unit review of records